课题基金 / 基金详情

Using Common Fund datasets for prioritization of disease-associated genetic variants

Using Common Fund datasets for prioritization of disease-associated genetic variants
使用共同基金数据集对与疾病相关的遗传变异进行优先排序
批准号:
10585864
负责人:
Ferhat Ay
金额:
$36.6万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-20 至 2024-09-19

项目摘要

项目成果

Ferhat Ay的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Genome-wide association studies (GWAS) have highlighted that disease-associated human genetic variants are prevalent in noncoding regions and for most of them the biological function or gene target remain uncharacterized. To better annotate such disease variants, NIH-funded consortia created comprehensive maps of putative regulatory elements and identified SNPs associated with gene expression (eQTLs) for different tissues and primary cell types. In parallel, breakthroughs in capturing the 3D genome structure have demonstrated the importance of cell-type-specific physical proximity between genes and their regulatory elements. This 3D view provided a new way through which disease-associations of certain variants can be explained. There is an increasing interest in utilization of chromatin loops for GWAS variant annotation, however, to the best of our knowledge, there is no comprehensive study incorporating eQTL data and high-resolution chromatin looping information across many different matched/related cell types and tissues to interpret GWAS variants identified for a large set of diseases. To goal of this proposal is to utilize NIH Common Fund datasets (GTEx and 4D Nucleome) as well as other published chromatin loop and eQTL data to carry out different integrative approaches for better annotation of disease-associated genetic variants. This will lead to the development of a framework and best practices for integrative analysis of loops, eQTLs and GWAS signals. The developed framework will be tested on a large number of diseases and disease-relevant cell types to create a substantial online resource for researchers. For a subset of the studied diseases, for which we have ongoing research interests, we will further analyze the identified novel genes, genetic variants and overlapping regulatory elements to determine potential targets that warrant further investigation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
SARS-CoV-2-reactive tissue-resident memory T cells in healthy and cancer subjects
Defining interaction quantitative trait loci (iQTLs) in the human genome
海外基金